BusinessCURE Pharmaceutical to Participate in Panel Discussion on the Future of Clinical Research using Cannabis at The Cannabis Science Conference in Portland, ORBy Nasdaq OMXAug 29, 2017, 1:01 PM UTC
BusinessCURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXAug 22, 2017, 3:19 PM UTC
BusinessAXIM Biotechnologies Reports Second Quarter 2017 ResultsBy Nasdaq OMXAug 22, 2017, 1:01 PM UTC
BusinessFDA Commissioner Scott Gottlieb’s Keynote Among Highly Anticipated Sessions at RAPS Regulatory ConvergenceBy Nasdaq OMXAug 10, 2017, 2:38 PM UTC
BusinessCURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfuntion Drug Using Company’s Proprietary CureFilm™ Into Asian MarketBy Nasdaq OMXAug 10, 2017, 1:00 PM UTC
BusinessMadrigal Pharmaceuticals Reports 2017 Second Quarter Financial ResultsBy Nasdaq OMXAug 10, 2017, 12:50 PM UTC
BusinessEarth Science Tech, Inc. Receives Update from Leading Independent Equity Research & Corporate Firm, SeeThruEquity with a Price Target of $4.12By Nasdaq OMXAug 10, 2017, 12:45 PM UTC
BusinessAnthera Pharmaceuticals Provides Business Update and Reports 2017 Second Quarter Financial ResultsBy Nasdaq OMXAug 9, 2017, 12:30 PM UTC
